Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -9.05 is 36% above its 5-year average of -14.25, near the high end of its 5-year range (-27.59–-9.02).
As of the fiscal period ended Monday, March 31, 2025. 52.95% above its 12-month average of -19.23.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 17 quarters.
Limited history available
ME PEG Ratio has fewer than three reported periods, so a trend chart would be misleading.
EARNINGS PER SHARE (EPS)
-9.05
EARNINGS PER SHARE (EPS) AVG TTM
-19.23
EARNINGS PER SHARE (EPS) AVG 3Y
-15.56
EARNINGS PER SHARE (EPS) AVG 5Y
-14.25
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+52.95%
CURRENT VS 3Y AVG
+41.84%
CURRENT VS 5Y AVG
+36.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
23andMe Holding Co.
Market Cap
$15.31M
Earnings Per Share (EPS)
-9.05
TTM Avg
-19.23
3Y Avg
-15.56
5Y Avg
-14.25
Market Cap
$471.59M
Earnings Per Share (EPS)
-2.17
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$1.22B
Earnings Per Share (EPS)
-0.99
TTM Avg
-3.50
3Y Avg
-23.24
5Y Avg
-16.84
Market Cap
$2.64B
Earnings Per Share (EPS)
4.37
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$2.68B
Earnings Per Share (EPS)
-3.15
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$6.19B
Earnings Per Share (EPS)
-0.09
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$7.69B
Earnings Per Share (EPS)
-1.44
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
Market Cap
$8.09B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 23andMe Holding Co. (ME) | $15.31M | -9.05 | -19.23 | -15.56 | -14.25 |
| NRC Health (NRC)vs › | $439.69M | 0.25 | 0.79 | 1.03 | 1.18 |
| Shoulder Innovations, Inc. (SI)vs › | $471.59M | -2.17 | -1.36 | -1.12 | -1.12 |
| Teladoc Health, Inc. (TDOC)vs › | $1.22B | -0.99 | -3.50 | -23.24 | -16.84 |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 4.37 | 3.33 | 1.17 | 0.32 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.68B | -3.15 | -3.74 | -3.13 | -1.84 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.19B | -0.09 | 0.57 | 0.18 | -0.06 |
| Tempus AI, Inc. (TEM)vs › | $7.69B | -1.44 | -3.00 | -2.43 | -2.16 |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | -0.54 | -0.79 | -1.41 | -1.76 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.80B | 6.07 | -18.74 | -45.28 | 14.90 |
Trailing EPS (TTM)
$-9.05
Forward EPS (Est.)
$-10.64
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-03-31 | -10.88 |
| 2024-03-31 | -27.59 |
| 2023-03-31 | -13.81 |
| 2022-03-31 | -9.96 |
| 2021-03-31 | -9.02 |
| 2020-03-31 | -14.24 |
| 2019-03-31 | -9.03 |
